Statin Use Is Associated with Reduced Risk of Haematological Malignancies: Evidence from a Meta-Analysis

Background Several observational studies have shown that statin use may modify the risk of haematological malignancies. To quantify the association between statin use and risk for haematological malignancies, we performed a detailed meta-analysis of published studies regarding this subject.